Cost-effectiveness of Biological Disease-modifying Antirheumatic Drugs for the Treatment of Rheumatoid Arthritis: Implications for Clinical Practice

2017-07-01

Journal of Rheumatology , Volume 44 - Issue 7 p. 965- 967

Additional Metadata
Persistent URL	doi.org/10.3899/jrheum.170334, hdl.handle.net/1765/100850
Journal	Journal of Rheumatology
Organisation	Rheumatology
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Kuijper, M., Buisman, L., Hazes, M., & Weel, A. (2017). Cost-effectiveness of Biological Disease-modifying Antirheumatic Drugs for the Treatment of Rheumatoid Arthritis: Implications for Clinical Practice. Journal of Rheumatology, 44(7), 965–967. doi:10.3899/jrheum.170334

Publication